z-logo
open-access-imgOpen Access
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Author(s) -
Almut Schulze,
Adrian L. Harris
Publication year - 2012
Publication title -
nature
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 15.993
H-Index - 1226
eISSN - 1476-4687
pISSN - 0028-0836
DOI - 10.1038/nature11706
Subject(s) - cancer , reprogramming , cancer cell , identification (biology) , biology , computational biology , bioinformatics , signalling pathways , metabolic pathway , cancer treatment , cancer research , metabolism , signal transduction , microbiology and biotechnology , genetics , biochemistry , cell , ecology
Cancer metabolism has received a substantial amount of interest over the past decade. The advances in analytical tools have, along with the rapid progress of cancer genomics, generated an increasingly complex understanding of metabolic reprogramming in cancer. As numerous connections between oncogenic signalling pathways and metabolic activities emerge, the importance of metabolic reprogramming in cancer is being increasingly recognized. The identification of metabolic weaknesses of cancer cells has been used to create strategies for treating cancer, but there are still challenges to be faced in bringing the drugs that target cancer metabolism to the clinic.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom